Mabtas RA 500mg Injection: Effective Relief for Your Condition

Mabtas RA 500mg Injection

Description:

• Contains the active constituent rituximab.
• Belongs to the class of medications called anti-CD20 monoclonal antibodies.

Uses:

• Non-Hodgkin’s lymphoma (NHL).
• Chronic lymphocytic leukemia (CLL).
• Rheumatoid arthritis.
• Granulomatosis with polyangiitis or microscopic polyangiitis.
• Pemphigus vulgaris.

Administration:

• Should only be administered by a trained doctor or nurse.
• Given as an intravenous infusion.
• Before administration, other medications (pre-medication) are given to reduce possible side effects.
• The dose and duration of treatment are decided by the doctor based on the severity of the disease and other factors.

Contraindications:

• Do not take if you are allergic to rituximab or any other ingredients of this medicine.
• Do not take if you have a weak immune system.
• Do not take if you have any severe active infection.
• Inform your physician if you have heart disease, heart failure, or breathing problems before initiating the treatment.
• Pregnancy and breastfeeding are not recommended when you are taking this injection.

Side Effects:

• Common: swelling in the face and body, diarrhea and nausea, itchy skin, anemia, muscle spasm, headache, urinary tract infection, fever, chills, and shivering, inflammation of nasal cavities, cough, sore throat, loss of hair.
• Serious: increased or decreased blood pressure, chest pain, hypersensitivity reactions, hepatitis B viral infection, memory loss, trouble thinking, difficulty in walking.

Precautions:

• Inform your healthcare provider about all the medicines you take.
• Store in the refrigerator (2°C to 8°C), do not freeze.
• Keep away from the reach of children and pets.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.
• Avoid vaccines before and during therapy.
• Report to your doctor immediately if you face any symptoms like chest pain, breathing difficulties, stomach pain, and skin reactions.

FAQs:

1. What are the special precautions I should be aware of before starting treatment with Mabtas RA 500mg injection?

   • Inform your doctor about your pre-existing conditions (heart, kidney, liver, hepatitis B, or lung disease) and vaccination history. It is necessary to consult a doctor if you are taking medicines for blood pressure.

2. What are Mabtas RA 500mg infusion-related reactions?

   • Infusion reactions occur during or within 24 hours after administering Mabtas RA 500mg injection. The symptoms are fever, chills, cough, itchy skin, nausea, vomiting, flushing, increased heart rate, and discomfort in the throat. Inform your physician immediately if you face any infusion-related reaction.

3. What will be the most important thing to monitor during Mabtas RA 500mg injection?

   • Your healthcare professional will monitor you carefully for unwanted side effects during the Mabtas RA 500mg injection. You will be monitored for heart failure, increased blood pressure, or breathing failure.

4. Is weight gain a side effect of Mabtas RA 500mg injection?

   • Weight gain has been reported in patients treated with Mabtas RA 500mg injection for non-Hodgkin’s lymphoma.

5. Does Mabtas RA 500mg injection suppress the immune system?

   • Yes, it can suppress the immune system, and the chances of catching an infection are high. Inform your doctor if you have a severe active infection before taking Mabtas RA 500mg injection because it may cause drug-induced immunosuppression.

Fact Box:

• Molecule name: Rituximab.
• Therapeutic class: Antineoplastics, DMARDs.
• Pharmacological class: Anti-CD20 monoclonal antibodies.

Tags: medical-drug, injection, RA-treatment, anti-inflammatory, pain-relief